Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | FASN | P49327 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | F7 | P08709 | 1/20 | 0.35 |
| ▸ | F3 | P13726 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11760854 | 1.00 | TSHR (0.50) | TSHRALDH1A1FASNFAAHTRPV1 | |
| SCHEMBL50222 | 0.97 | — | — | |
| SCHEMBL27526741 | 0.97 | — | — | |
| SCHEMBL6474996 | 0.97 | — | — | |
| SCHEMBL50221 | 0.97 | — | — | |
| SCHEMBL6893971 | 0.95 | TSHR (0.50) | TSHRALDH1A1FASNFAAHTRPV1 | |
| Charcoal, Activated SCHEMBL31543059 | 0.95 | — | — | |
| SCHEMBL6893975 | 0.95 | TSHR (0.50) | TSHRALDH1A1FASNFAAHTRPV1 | |
| Water SCHEMBL20580085 | 0.95 | — | — | |
| Hydrogen Sulfide SCHEMBL28789251 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112219258-B | Spin-on metallization | 弗萨姆材料美国有限责任公司 | 2024-12-31 | — | — | CN | disclosed |
| US-8236920-B2 | Polyarylene and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-07 | — | — | US | disclosed |
| EP-1995265-B1 | POLYARYLENE AND PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2012-08-01 | — | — | EP | disclosed |
| EP-1935916-B1 | POLYARYLENE AND PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2012-05-23 | — | — | EP | disclosed |
| US-20090036632-A1 | Polyarylene and Process for Producing the Same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-02-05 | — | — | US | disclosed |
| EP-1995265-A1 | POLYARYLENE AND PROCESS FOR PRODUCING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-20080287646-A1 | Polyarylene and Method for Producing the Same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2008-11-20 | — | — | US | disclosed |
| EP-1935916-A1 | POLYARYLENE AND PROCESS FOR PRODUCING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-4020118-A | CATALYTIC | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JA) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036632-A1 | Polyarylene and Process for Producing the Same | CYP1A1, CYP1B1, C1R | TSHR 69/4885ALDH1A1 1881/4885FASN 877/4885 |
| US-20080287646-A1 | Polyarylene and Method for Producing the Same | CYP1A1, C1R, CBR1 | TSHR 307/4885ALDH1A1 602/4885FASN 1921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.